Calumet Specialty Products Partners, L.P. EPS of -$0.27

Calumet Specialty Products Partners, L.P. (CLMT): Q4 EPS of -$0.27 may not be comparable to consensus of $0.06.

Revenue of $1.24B (+1.6% Y/Y) misses by $20M.

Comments (2)
  • Charles12345
    , contributor
    Comments (138) | Send Message
    Honestly, SeekingAlpha scares me. It wasn't long ago that authors here we're touting Calumnet Specialty Products as a stock to hold forever in your portfolio, as a golden child, as one that couldn't possibly miss… and wow has it been suffering!


    I am beginning to think that it is possibly too easy for authors to shore up their positions in a stock by raving about here. Or, to help their short positions, by slamming the stock here.


    I believe there is little doubt that the writings on SeekingAlpha do have an impact stock price. And therefore it behooves every investor to read these posts, with a very large grain of salt.


    And I think it's a good idea to question very strongly any article that is on here...
    19 Feb 2014, 12:25 PM Reply Like
  • ComputerBlue
    , contributor
    Comments (1396) | Send Message
    While I agree it can be challenging to decipher the variety of the "opinion" pieces listed on SA, there are quite a few good authors that are worth following. In regards to CLMT, Bret Jensen (sp) is one of my favorites for CLMT info. Given CLMT's performance of the last year, like yourself, I am somewhat disappointed but I understand their model and structure can attribute to subpar performance in the short term. Long term, they are making good decisions.
    19 Feb 2014, 02:33 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs